These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22177105)

  • 1. Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis.
    Clements PJ; Allanore Y; Khanna D; Singh M; Furst DE
    Semin Arthritis Rheum; 2012 Jun; 41(6):801-14. PubMed ID: 22177105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musculoskeletal involvement in systemic sclerosis.
    Lóránd V; Czirják L; Minier T
    Presse Med; 2014 Oct; 43(10 Pt 2):e315-28. PubMed ID: 25179276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Points to consider for designing trials in systemic sclerosis patients with arthritic involvement.
    Clements P; Allanore Y; Furst DE; Khanna D
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v23-v26. PubMed ID: 28992165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
    Horimoto AM; da Costa IP
    Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
    Yuen SY; Rochwerg B; Ouimet J; Pope JE
    J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
    Ingegnoli F; Carmona L; Castrejon I
    Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthritis in patients with systemic sclerosis.
    Schmeiser T; Pons-Kühnemann J; Özden F; Müller-Ladner U; Dinser R
    Eur J Intern Med; 2012 Jan; 23(1):e25-9. PubMed ID: 22153544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Articular involvement in systemic sclerosis.
    Avouac J; Clements PJ; Khanna D; Furst DE; Allanore Y
    Rheumatology (Oxford); 2012 Aug; 51(8):1347-56. PubMed ID: 22467084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musculoskeletal Manifestations of Systemic Sclerosis.
    Morrisroe KB; Nikpour M; Proudman SM
    Rheum Dis Clin North Am; 2015 Aug; 41(3):507-18. PubMed ID: 26210132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
    Schieir O; Thombs BD; Hudson M; Boivin JF; Steele R; Bernatsky S; Hanley J; Baron M;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):409-17. PubMed ID: 20391488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Musculoskeletal hand involvement in systemic sclerosis.
    Sandler RD; Matucci-Cerinic M; Hughes M
    Semin Arthritis Rheum; 2020 Apr; 50(2):329-334. PubMed ID: 31812353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye.
    Kreps EO; Carton C; Cutolo M; Cutolo CA; Vanhaecke A; Leroy BP; Smith V
    Semin Arthritis Rheum; 2019 Aug; 49(1):119-125. PubMed ID: 30660382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6.
    Merkel PA; Clements PJ; Reveille JD; Suarez-Almazor ME; Valentini G; Furst DE;
    J Rheumatol; 2003 Jul; 30(7):1630-47. PubMed ID: 12858472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of skin involvement in systemic sclerosis.
    Kumánovics G; Péntek M; Bae S; Opris D; Khanna D; Furst DE; Czirják L
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v53-v66. PubMed ID: 28992173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.
    Khanna D; Brown KK; Clements PJ; Elashoff R; Furst DE; Goldin J; Seibold JR; Silver RM; Tashkin DP; Wells AU
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S55-62. PubMed ID: 20576216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis.
    Stamenković B; Stanković A; Dimić A; Damjanov N; Nedović J; Stojanović S; Savić V; Djordjević D
    Srp Arh Celok Lek; 2012; 140(5-6):350-4. PubMed ID: 22826990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.